Multiple myeloma

Expression and significance of miR-21 in multiple myeloma patients

J. H. Wang, Zhou, W. W., Liu, B. X., Man, D. L., Yang, Z. D., Liu, F. R., Shang, H., Wang, J. H., Zhou, W. W., Liu, B. X., Man, D. L., Yang, Z. D., Liu, F. R., Shang, H., Wang, J. H., Zhou, W. W., Liu, B. X., Man, D. L., Yang, Z. D., Liu, F. R., and Shang, H., Expression and significance of miR-21 in multiple myeloma patients, vol. 15, p. -, 2016.

The aim of the present study is to examine the expression level of peripheral mir-21 in multiple myeloma (MM) patients and to determine its clinical significance. MM patients (30), monoclonal gammopathy of undetermined significance (MGUS) patients (14), and normal controls (20) were recruited to determine the serum level of β2-MG, IgA and IgM, IgG, λ, κ, TP, ALB, Hb, LDH, and Ca2+. Gene expression of mir-21 was quantified by SYBR green real-time fluorescent quantitative PCR.

Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma

S. Wang, Huang, Y., Su, R., Fang, Z., and Han, M., Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma, vol. 14, pp. 5856-5861, 2015.

Cyclin D1 is an important cell cycle regulator implicated in the pathogenesis of many cancer types. In particular, translocation and overexpression of cyclin D1 are common events in multiple myeloma (MM), suggesting that it may drive the initiation and progression of this malignancy. However, the association between genetic polymorphisms of cyclin D1 and the risk for developing MM remains poorly characterized. We performed a case-control study with 67 patients with MM and 66 healthy controls in a Chinese population.

The G1138A mutation rate in the fibroblast growth factor receptor 3 (FGFR3) gene is increased in cells carrying the t (4; 14) translocation

P. L. Reddy and Grewal, R. P., The G1138A mutation rate in the fibroblast growth factor receptor 3 (FGFR3) gene is increased in cells carrying the t (4; 14) translocation, vol. 8, pp. 435-439, 2009.

Spontaneous mutations are a common phenomenon, occurring in both germ-line and somatic genomes. They may have deleterious consequences including the development of genetic disorders or, when occurring in somatic tissues, may participate in the process of carcinogenesis. Similar to many mutational hotspots, the G1138A mutation in the fibroblast growth factor receptor 3 (FGFR3) gene occurs at a CpG site. In germ-line tissues, the G1138A mutation results in achondroplasia and has one of the highest spontaneous mutation rates in the human genome.

Subscribe to Multiple myeloma